
The Washington Post @washingtonpost
The Pfizer-BioNTech vaccine’s effectiveness in children 5 to 11 years old waned over time although the shot continued to protect against the most serious outcomes, including hospitalization and death, even as omicron surged, newly released data shows https://t.co/VBHIIx7SAz — PolitiTweet.org